Skip to main content
. 2023 Sep 14;8:348. doi: 10.1038/s41392-023-01614-1

Fig. 4.

Fig. 4

Multivariate COX results of sorafenib maintenance post-transplantation effects on the subgroups with different ELN risk groups, FLT3-ITD AR, and genetic patterns